# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA630753 | A | Reactivation time of the compound | 1 | ALA1125311 | assay format | Scientific Literature | ||
2. | ALA634788 | A | Half-life value of the compound. | 15 | ALA1125311 | assay format | Scientific Literature | ||
3. | ALA634833 | P | Tested for chemical stability of the compound | 13 | ALA1127140 | small-molecule physicochemical format | Scientific Literature | ||
4. | ALA635981 | A | Half life. | 2 | ALA1133572 | assay format | Scientific Literature | ||
5. | ALA642520 | B | Inhibitory activity against Acetylcholinesterase at 10 min (48 mM conc) | 1 | ALA1125311 | single protein format | Scientific Literature | ||
6. | ALA661892 | B | Inhibitory activity against Cathepsin G at 10 min (48 mM conc)using 0.2 mM Tosyl-Gly-Pro-Arg-p-nitroanilide as substrate | 1 | ALA1125311 | single protein format | Scientific Literature | ||
7. | ALA673104 | B | Inhibitory activity against HLE at 10 min (48 mM conc) | 1 | ALA1125311 | single protein format | Scientific Literature | ||
8. | ALA674076 | B | Inhibition of elastase. | 2 | ALA1133572 | single protein format | Scientific Literature | ||
9. | ALA674088 | B | Inhibition of Elastase using Suc-Ala-Ala-Pro-Ala-pNA as substrate, activity expressed as Kobs/[I] (second order rate constant) | Homo sapiens | 13 | ALA1127140 | single protein format | Scientific Literature | |
10. | ALA674749 | B | In vitro inhibitory activity against human leukocyte elastase | 34 | ALA1125311 | single protein format | Scientific Literature | ||
11. | ALA676331 | F | Inhibition of elastin solubilization | 1 | ALA1125311 | assay format | Scientific Literature | ||
12. | ALA695323 | F | Inhibitory activity against Human Leukocyte Elastase by Lung Hemorrhage assay | Cricetulus griseus | 1 | ALA1125311 | organism-based format | Scientific Literature | |
13. | ALA689398 | F | Inhibition of lung hemorrhage at 200 ug/animal | Cricetulus griseus | 1 | ALA1125311 | organism-based format | Scientific Literature | |
14. | ALA690241 | F | Effective dose administered intratracheally required to give 50% inhibition at 30 minutes prior to installation of human leukocyte elastase in hamster lung | Cricetulus griseus | 7 | ALA1125952 | organism-based format | Scientific Literature | |
15. | ALA690254 | F | Inhibitory activity against Human Leukocyte Elastase by Lung Hemorrhage assay (Effective dose at 15 microg) | Cricetulus griseus | 3 | ALA1125311 | organism-based format | Scientific Literature | |
16. | ALA692623 | F | Compound at dose 20 ug was tested for percentage inhibition of HLE-induced Lung Hemorrhage in hamsters at 1 hr prior to installation of human leukocyte elastase | Cricetulus griseus | 7 | ALA1125952 | organism-based format | Scientific Literature | |
17. | ALA692624 | F | Compound at dose 20 ug was tested for percentage inhibition of HLE-induced Lung Hemorrhage in hamsters at 2 hr prior to installation of human leukocyte elastase | Cricetulus griseus | 7 | ALA1125952 | organism-based format | Scientific Literature | |
18. | ALA690987 | F | Compound at dose 20 ug was tested for percentage inhibition of HLE-induced Lung Hemorrhage in hamsters at 3 hr prior to installation of human leukocyte elastase | Cricetulus griseus | 7 | ALA1125952 | organism-based format | Scientific Literature | |
19. | ALA690988 | F | Compound at dose 20 ug was tested for percentage inhibition of HLE-induced Lung Hemorrhage in hamsters at 4 hr prior to installation of human leukocyte elastase | Cricetulus griseus | 7 | ALA1125952 | organism-based format | Scientific Literature | |
20. | ALA690394 | F | Compound was evaluated in vivo for inhibition of HLE-induced hemorrhage in hamster lung at 10 microg 30 min after administration prior to HLE | Cricetulus griseus | 1 | ALA1125311 | organism-based format | Scientific Literature |